These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21527114)

  • 1. Indian Diabetes Risk Score helps to distinguish type 2 from non-type 2 diabetes mellitus (GDRC-3).
    Sharma KM; Ranjani H; Nguyen H; Shetty S; Datta M; Narayan KM; Mohan V
    J Diabetes Sci Technol; 2011 Mar; 5(2):419-25. PubMed ID: 21527114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum adiponectin helps to differentiate type 1 and type 2 diabetes among young Asian Indians.
    Gokulakrishnan K; Aravindhan V; Amutha A; Abhijit S; Ranjani H; Anjana RM; Unnikrishnan R; Miranda P; Narayan KM; Mohan V
    Diabetes Technol Ther; 2013 Aug; 15(8):696-702. PubMed ID: 23902401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of Indian diabetic risk score in diagnosing type 2 diabetes mellitus against high fasting blood sugar levels among adult population of central India.
    Bhadoria AS; Kasar PK; Toppo NA
    Biomed J; 2015; 38(4):359-60. PubMed ID: 25355391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Implications of Urinary C-Peptide Creatinine Ratio in Patients with Different Types of Diabetes.
    Wang Y; Gao Y; Cai X; Chen L; Zhou L; Ma Y; Gong S; Han X; Ji L
    J Diabetes Res; 2019; 2019():1747684. PubMed ID: 31485449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening with OGTT alone or in combination with the Indian diabetes risk score or genotyping of TCF7L2 to detect undiagnosed type 2 diabetes in Asian Indians.
    Mohan V; Goldhaber-Fiebert JD; Radha V; Gokulakrishnan K
    Indian J Med Res; 2011 Mar; 133(3):294-9. PubMed ID: 21441683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simplified Indian Diabetes Risk Score for screening for undiagnosed diabetic subjects.
    Mohan V; Deepa R; Deepa M; Somannavar S; Datta M
    J Assoc Physicians India; 2005 Sep; 53():759-63. PubMed ID: 16334618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the Performance of the Indian Diabetes Risk Score in Different Ethnic Groups.
    Nugawela MD; Sivaprasad S; Mohan V; Rajalakshmi R; Netuveli G
    Diabetes Technol Ther; 2020 Apr; 22(4):285-300. PubMed ID: 31825242
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of risk of diabetes by using Indian Diabetic risk score (IDRS) in Indian population.
    Nagarathna R; Tyagi R; Battu P; Singh A; Anand A; Nagendra HR
    Diabetes Res Clin Pract; 2020 Apr; 162():108088. PubMed ID: 32087269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of ICD-10-CM codes for determination of diabetes type for persons with youth-onset type 1 and type 2 diabetes.
    Chi GC; Li X; Tartof SY; Slezak JM; Koebnick C; Lawrence JM
    BMJ Open Diabetes Res Care; 2019; 7(1):e000547. PubMed ID: 30899525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choosing the most appropriate existing type 2 diabetes risk assessment tool for use in the Philippines: a case-control study with an urban Filipino population.
    Agarwal G; Guingona MM; Gaber J; Angeles R; Rao S; Cristobal F
    BMC Public Health; 2019 Aug; 19(1):1169. PubMed ID: 31455247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity indicators that best predict type 2 diabetes in an Indian population: insights from the Kerala Diabetes Prevention Program.
    Kapoor N; Lotfaliany M; Sathish T; Thankappan KR; Thomas N; Furler J; Oldenburg B; Tapp RJ
    J Nutr Sci; 2020; 9():e15. PubMed ID: 32328239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Risk-Score Model for Type 2 Diabetes: A Cohort Study of a Rural Adult Chinese Population.
    Zhang M; Zhang H; Wang C; Ren Y; Wang B; Zhang L; Yang X; Zhao Y; Han C; Pang C; Yin L; Xue Y; Zhao J; Hu D
    PLoS One; 2016; 11(4):e0152054. PubMed ID: 27070555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The product of fasting plasma glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged Koreans.
    Lee JW; Lim NK; Park HY
    BMC Endocr Disord; 2018 May; 18(1):33. PubMed ID: 29843706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recalibrating the Non-Communicable Diseases risk prediction tools for the rural population of Western India.
    Gupta MK; Raghav P; Tanvir T; Gautam V; Mehto A; Choudhary Y; Mittal A; Singh G; Singh G; Baskaran P; Rehana VR; Jabbar SA; Sridevi S; Goel AD; Bhardwaj P; Saurabh S; Srikanth S; Naveen KH; Prasanna T; Rustagi N; Sharma PP
    BMC Public Health; 2022 Feb; 22(1):376. PubMed ID: 35193546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary C-peptide creatinine ratio to differentiate type 2 diabetes mellitus from type 1 in pediatric patients.
    Elzahar W; Arafa A; Youssef A; Erfan A; El Amrousy D
    Eur J Pediatr; 2020 Jul; 179(7):1115-1120. PubMed ID: 32052124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the MDRF-Indian Diabetes Risk Score (IDRS) in another south Indian population through the Boloor Diabetes Study (BDS).
    Adhikari P; Pathak R; Kotian S
    J Assoc Physicians India; 2010 Jul; 58():434-6. PubMed ID: 21121209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic values and appropriate cutoff points of lipid ratios in patients with abnormal glucose tolerance status: a cross-sectional study.
    Guo W; Qin P; Lu J; Li X; Zhu W; Xu N; Wang J; Zhang Q
    Lipids Health Dis; 2019 Jun; 18(1):130. PubMed ID: 31153374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A risk-score model for predicting risk of type 2 diabetes mellitus in a rural Chinese adult population: A cohort study with a 6-year follow-up.
    Zhang H; Wang C; Ren Y; Wang B; Yang X; Zhao Y; Han C; Zhou J; Zhang L; Qi M; Zhai Y; Pang C; Yin L; Zhao J; Hu D; Zhang M
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28608942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settings.
    Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW
    PLoS One; 2021; 16(3):e0248469. PubMed ID: 33788827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis.
    Katz LE; Jawad AF; Ganesh J; Abraham M; Murphy K; Lipman TH
    Pediatr Diabetes; 2007 Apr; 8(2):53-9. PubMed ID: 17448127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.